Basics Aprea Therapeutics, Inc. IPO Date: September 30, 2019 Sector: Healthcare Industry: Biotech Market Cap: $9.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 3.71% Avg Daily Range (30 D): $0.05 | 2.72% Avg Daily Range (90 D): $0.06 | 3.45% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .03M Trade Size Avg Trade Size (Sh.): 204 Avg Trade Size (Sh.) (30 D): 250 Avg Trade Size (Sh.) (90 D): 211 Institutional Trades Total Inst.Trades: 121 Avg Inst. Trade: $1.73M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 7.56K     News Jun 25, 2025 @ 1:00 PM Aprea Reports Anti-Proliferative Results and Promi... Source: N/A May 14, 2025 @ 12:00 PM Aprea Therapeutics Reports First Quarter 2025 Fina... Source: N/A Jun 21, 2024 @ 12:00 PM Aprea Therapeutics to Host Virtual KOL Event on AP... Source: Aprea Therapeutics Jun 17, 2024 @ 12:30 PM Aprea Therapeutics Announces First Patient Dosed i... Source: Aprea Therapeutics May 28, 2024 @ 12:45 PM Aprea Therapeutics Announces that Safety Review Co... Source: Aprea Therapeutics Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.3 $-.53 $-.66 Diluted EPS $-2.4 $-.53 $-.66 Revenue $ .84M $ .12M $ .16M Gross Profit $ $ $ Net Income / Loss $ -13.85M $ -3.24M $ -3.93M Operating Income / Loss $ -14.8M $ -3.39M $ -4.09M Cost of Revenue $ $ $ Net Cash Flow $ -5.85M $ M $ M PE Ratio     Splits Feb 13, 2023:   1:20 Dec 27, 2018:   1:1000 Sep 13, 2011:   1:500